On March 11, 2023, the "Third Training Course on Standardized Diagnosis and Treatment of Space Animal Injuries (Nanjing Station)" hosted by the Alliance of Emergency and Critical Doctors and the Aerospace Center Hospital was successfully held in Nanjing, Jiangsu. Liaoning Chengda Biological Co., Ltd. participated and Co-organized this meeting.

 

The opening ceremony of the meeting was presided over by Qian Yuehua, Center for Disease Control and Prevention of Qinhuai District, Nanjing

 

Speech by Yang Bin, Deputy Director of Nanjing Gulou District Center for Disease Control and Prevention

 

Director Yang Bin said that in order to further improve the theoretical knowledge and practical skills of medical staff in the treatment of animal injury exposure, to ensure that the treatment of animal injury exposure is carried out in a standardized and orderly manner, and to make the level of prevention and control more precise and professional, we still need Continuous learning and improvement.

 

 

SpaceXie Pingchu, Deputy Minister of the Management Department of Medical Hospitals, Wang Xudong, Chairman of the Aerospace Emergency and Critical Care Doctors Union,Nanjing Aerospace Hospital President Wu Yun delivered a speech respectively

 

The Aerospace Emergency and Critical Doctors Alliance has been constantly exploring new models and technologies for animal injuries, continuously applying for national continuing education projects every year, and successfully holding three national conferences to contribute academic strength to the industry.

The academic report in the morning was givenNantong Haimen District People's Hospital Army Director presided over

 

Feng Zhi, deputy director of Nanjing Jiangning District Center for Disease Control and Prevention, shares the construction of rabies exposure prevention and treatment clinic

 

Hua Jinyun, Director of Yangzhou Center for Disease Control and Prevention, shared "Treatment of Animal Injuries under the New Situation of New Crown Epidemic"

 

Director Zhao Jing of Xuzhou Mine Hospital shared "Rabies pre-exposure immunization"

 

Li Hu, director of Beijing Luhe Hospital affiliated to Capital Medical University, shares the clinical application of human rabies vaccine

 

The conference satellite will beYin Li of Liaoning Chengda Biology Co., Ltd. shared "Chengda Suda"^®Product Introduction

Chengda^®ProductsThe advantages are obvious, the characteristics are outstanding, and the product quality is uniform and stable. The process platform technology for the large-scale preparation of vaccines in its bioreactor is a prerequisite for product stability and supply stability. In the event of major events in the industry, Chengda Bio provides a continuous and stable supply for the human rabies vaccine market, contributing to the protection of patients' use.

 

In the afternoon, Director Peng Yigen of Jiangning People's Hospital of Nanjing presided over the academic report.

 

Jiang Hao, Director of Nanjing Second Hospital, Share the Development of Rabies Passive Immune Preparations

 

Director Liu Ning of Nanjing Second Hospital shared "Plastic Surgery Repair of Animal Bites on Head and Face"

Next, Li Yunqing, director of Nanjing Aerospace Hospital, presided over the academic report.

 

Director Huang Lisong of Aerospace Center Hospital shared "New Technology of Animal Injury Treatment"

 

Director Huang Lisong and Director Li Hu answered questions on the spot.

Academic Report Part Successfully Concluded

 

Director Huang Lisong of Aerospace Center Hospital demonstrated the operation

 

After the academic report, nearly50 participants visited the Nanjing Aerospace Hospital Animal Injury Treatment Clinic. Director Huang Lisong was invited to demonstrate and guide the prevention and treatment of rabies after exposure, rabies vaccination, use of passive immune preparations and wound cleaning.

 

Rabies is an almost 100% fatal disease, and post-exposure prophylaxis is particularly important. This academic conference strengthened academic exchanges in the field of rabies prevention and control, provided more learning and exchange opportunities for rabies prevention and control managers and outpatient medical staff, and further improved the technical level of rabies prevention and treatment after exposure. The practical part focuses on the analysis of the problems and pain points in the clinical operation, and effectively improves the clinical ability and level of primary medical staff.

 

"Two programs, billion-level guardians".

Chengda^®As the first domestic use experience over0.1 billion human rabies vaccine products, with its stable production technology and excellent quality, have been widely recognized while providing a stable supply for the market.